Rivaroxaban is an anticoagulant used to prevent and treat blood clots in conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It works by inhibiting factor Xa, a key enzyme in the coagulation cascade, thereby preventing thrombus formation. Rivaroxaban is essential for reducing the risk of serious cardiovascular events related to blood clots. In summary, Rivaroxaban is vital for managing thromboembolic disorders.
Rivaroxaban selectively inhibits factor Xa, preventing the conversion of prothrombin to thrombin and subsequently inhibiting fibrin formation.









